Cargando…
Development and validation of LC–MS/MS with in-source collision-induced dissociation for the quantification of pegcantratinib in human skin tumors
AIM: Pegcantratinib is a mini-PEGylated K252a derivative, under clinical evaluation as an anticancer agent acting through inhibition of the tropomyosin receptor kinase. A method for quantifying pegcantratinib in skin tumor biopsies of patients was required to determine tumor drug penetration. METHOD...
Autores principales: | Zangarini, Monique, Rajan, Neil, Danilenko, Marina, Berry, Philip, Traversa, Silvio, Veal, Gareth J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292016/ https://www.ncbi.nlm.nih.gov/pubmed/28111963 http://dx.doi.org/10.4155/bio-2016-0199 |
Ejemplares similares
-
Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical Trial
por: Danilenko, Marina, et al.
Publicado: (2018) -
Liquid Chromatography Electron Capture Dissociation Tandem Mass Spectrometry (LC-ECD-MS/MS) versus Liquid Chromatography Collision-induced Dissociation Tandem Mass Spectrometry (LC-CID-MS/MS) for the Identification of Proteins
por: Creese, Andrew J., et al.
Publicado: (2007) -
Stoichiometric Quantification of Akt Phosphorylation Using LC-MS/MS
por: Atrih, Abdelmadjid, et al.
Publicado: (2009) -
Pipelines and Systems for Threshold-Avoiding Quantification
of LC–MS/MS Data
por: Sánchez Brotons, Alejandro, et al.
Publicado: (2021) -
Estimation of measurement uncertainty for the quantification of protein by ID-LC–MS/MS
por: Beasley-Green, Ashley, et al.
Publicado: (2023)